The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats
Open accessAbstract
Background & aims Visceral hypersensitivity is one feature of irritable bowel syndrome (IBS). Bacterial dysbiosis might be involved in the activation of nociceptive sensory pathways, but there have been few studies of the role of the mycobiome (the fungal microbiome) in the development of IBS. We analyzed intestinal mycobiomes of patients with IBS and a rat model of visceral hypersensitivity.Methods We used internal transcribed spacer 1-based metabarcoding to compare fecal mycobiomes of 18 healthy volunteers with those of 39 patients with IBS (with visceral hypersensitivity or normal levels of sensitivity). We also compared the mycobiomes of Long-Evans rats separated from their mothers (hypersensitive) with non-handled (normally sensitive) rats. We investigated whether fungi can cause visceral hypersensitivity using rats exposed to fungicide (fluconazole and nystatin). The functional relevance of the gut mycobiome was confirmed in fecal transplantation experiments: adult maternally separated rats were subjected to water avoidance stress (to induce visceral hypersensitivity), then given fungicide and donor cecum content via oral gavage. Other rats subjected to water avoidance stress were given soluble β-glucans, which antagonize C-type lectin domain family 7 member A (CLEC7A or DECTIN1) signaling via spleen-associated tyrosine kinase (SYK), a SYK inhibitor to reduce visceral hypersensitivity, or vehicle (control). The sensitivity of mast cells to fungi was tested with mesenteric windows (ex vivo) and the human mast cell line HMC-1.Results α diversity (Shannon index) and mycobiome signature (stability selection) of both groups of IBS patients differed from healthy volunteers, and the mycobiome signature of hypersensitive patients differed from that of normally sensitive patients. We observed mycobiome dysbiosis in rats that had been separated from their mothers compared with non-handled rats. Administration of fungicide to hypersensitive rats reduced their visceral hypersensitivity to normal levels of sensitivity. Administration of cecal mycobiomes from rats that had been separated from their mothers (but not non-handled mycobiome) restored hypersensitivity to distension. Administration of soluble β-glucans or a SYK inhibitor reduced visceral hypersensitivity, compared with controls. Particulate β-glucan (a DECTIN-1 agonist) induced mast cell degranulation in mesenteric windows and HMC-1 cells responded to fungal antigens by release of histamine.Conclusions In an analysis of patients with IBS and controls, we associated fungal dysbiosis with IBS. In studies of rats, we found fungi to promote visceral hypersensitivity, which could be reduced by administration of fungicides, soluble β-glucans, or a SYK inhibitor. The intestinal fungi might therefore be manipulated for treatment of IBS-related visceral hypersensitivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also neglected to date is the gut mycobiome, and there are indications that our intestinal fungi are an important component of host-microbe interactions of relevance to immune homeostasis and inflammatory disorders (Leonardi et al., 2018) and stress-related disorders such as irritable bowel syndrome (Botschuijver et al., 2017).”
From Gut reactions: Breaking down xenobiotic–microbiome interactions (2019) · cites this paper as Botschuijver et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779
Jost, L. (2006) · Oikos · doi:10.1111/j.2006.0030-1299.14714.x · Cited by 4,669
Meinshausen, N., & Bühlmann, P. (2010) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1111/j.1467-9868.2010.00740.x · Cited by 2,463
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
Drossman, D. A. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.032 · Cited by 2,444
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155
Fungal microbiota dysbiosis in IBD
Sokol, H., Leducq, V., Aschard, H., Pham, H., Jégou, S., Landman, C., Cohen, D., Liguori, G., Bourrier, A., Nion–Larmurier, I., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310746 · Cited by 1,382
How informative is the mouse for human gut microbiota research?
Nguyen, T. L. A., Vieira-Silva, S., Liston, A., & Raes, J. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.017400 · Cited by 1,334
Dectin-1 Mediates the Biological Effects of β-Glucans
Brown, G. D., Herre, J., Williams, D. L., Willment, J. A., Marshall, A. S. J., & Gordon, S. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021890 · Cited by 1,209
Dectin-1 is required for β-glucan recognition and control of fungal infection
Taylor, P. R., Tsoni, S. V., Willment, J. A., Dennehy, K. M., Rosas, M., Findon, H., Haynes, K., Steele, C. H., Botto, M., Gordon, S., et al. (2006) · Nature Immunology · doi:10.1038/ni1408 · Cited by 1,185
Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis
Iliev, I. D., Funari, V. A., Taylor, K. D., Nguyen, Q., Reyes, C. N., Strom, S. P., Brown, J., Becker, C. A., Fleshner, P. R., Dubinsky, M., et al. (2012) · Science · doi:10.1126/science.1221789 · Cited by 1,073
Research works printed but not linked: 1
- Dukes, 2009, A randomised double blind, placebo controlled, crossover study to evaluate the efficacy and safety of the corticotrophin releasing factor 1 (CRF1) receptor antagonist GW876008 in IBS patients, Neurogastroenterol Motil, 21, 84
Cited by
Sorted by citations
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Kootte, R. S., Levin, E., Salojärvi, J., Smits, L. P., Hartstra, A. V., Udayappan, S. D., Hermes, G., Bouter, K. E., Koopen, A. M., Holst, J. J., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.008 · Cited by 1,039
Self-citationVu, D., Groenewald, M., de Vries, M., Gehrmann, T., Stielow, J. B., Eberhardt, U., Al‐Hatmi, A. M. S., Groenewald, J. Z., Cardinali, G., Houbraken, J. A. M. P., et al. (2018) · Studies in Mycology · doi:10.1016/j.simyco.2018.05.001 · Cited by 1,010
Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer
Coker, O. O., Nakatsu, G., Dai, R. Z., Wu, W. K. K., Wong, S. H., Ng, S. C., Chan, F. K. L., Sung, J. J. Y., & Yu, J. (2019) · Gut · doi:10.1136/gutjnl-2018-317178 · Cited by 511
Gut microbiome, liver immunology, and liver diseases
Wang, R., Tang, R., Li, B., Ma, X., Schnabl, B., & Tilg, H. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00592-6 · Cited by 466
Richard, M. L., & Sokol, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0121-2 · Cited by 428
Zhang, F., Aschenbrenner, D., Yoo, J. Y., & Zuo, T. (2022) · The Lancet Microbe · doi:10.1016/s2666-5247(22)00203-8 · Cited by 424
Chong, P. P., Chin, V. K., Looi, C. Y., Wong, W. F., Madhavan, P., & Yong, P. V. C. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01136 · Cited by 353
Gut reactions: Breaking down xenobiotic–microbiome interactions
Clarke, G., Sandhu, K. V., Griffin, B. T., Dinan, T. G., Cryan, J. F., & Hyland, N. P. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.015768 · Cited by 319
Investigating Colonization of the Healthy Adult Gastrointestinal Tract by Fungi
Auchtung, T. A., Fofanova, T. Y., Stewart, C. J., Nash, A. K., Wong, M. C., Gesell, J. R., Auchtung, J. M., Ajami, N. J., & Petrosino, J. F. (2018) · mSphere · doi:10.1128/msphere.00092-18 · Cited by 296
Gut Microbiota beyond Bacteria—Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD
Matijašić, M., Meštrović, T., Paljetak, H. Č., Perić, M., Barešić, A., & Verbanac, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082668 · Cited by 315
Grundy, L., Erickson, A., & Brierley, S. M. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114525 · Cited by 256
Wang, L., Alammar, N., Singh, R., Nanavati, J., Song, Y., Chaudhary, R., & Mullin, G. E. (2019) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2019.05.015 · Cited by 251
Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
Presti, A. L., Zorzi, F., CHIERICO, F. D., Altomare, A., Cocca, S., Avola, A., Biasio, F. D., Russo, A., Cella, E., Reddel, S., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01655 · Cited by 228
Paediatric functional abdominal pain disorders
Thapar, N., Benninga, M. A., Crowell, M. D., Di Lorenzo, C., Mack, I., Nurko, S., Saps, M., Shulman, R. J., Szajewska, H., van Tilburg, M. A. L., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00222-5 · Cited by 221
A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies
Rodiño‐Janeiro, B. K., Vicario, M., Alonso, C., Pascua-García, R., & Santos, J. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0673-5 · Cited by 223
Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects
Bouter, K. E. C., Bakker, G. J., Levin, E., Hartstra, A. V., Kootte, R. S., Udayappan, S. D., Katiraei, S., Bahler, L., Gilijamse, P. W., Tremaroli, V., et al. (2018) · Clinical and Translational Gastroenterology · doi:10.1038/s41424-018-0025-4 · Cited by 208
Pathology of pain and its implications for therapeutic interventions
Cao, B., Xu, Q., Shi, Y., Zhao, R., Li, H., Zheng, J., Liu, F., Wan, Y., & Wei, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01845-w · Cited by 236
The gut microbiome and irritable bowel syndrome
Menees, S., & Chey, W. (2018) · F1000Research · doi:10.12688/f1000research.14592.1 · Cited by 159
“Recent data suggest that the community of fungi or “mycobiome” is also altered in patients with IBS and may be associated with the development of visceral hypersensitivity 20 .”
BackgroundSimpson, C. A., Mu, A., Haslam, N., Schwartz, O., & Simmons, J. G. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.124 · Cited by 174
Vemuri, R., Shankar, E. M., Chieppa, M., Eri, R., & Kavanagh, K. (2020) · Microorganisms · doi:10.3390/microorganisms8040483 · Cited by 162
Mycobiome in the Gut: A Multiperspective Review
Chin, V. K., Yong, P. V. C., Chong, P. P., Nordin, S. A., Basir, R., & Abdullah, M. (2020) · Mediators of Inflammation · doi:10.1155/2020/9560684 · Cited by 161
Gheorghe, C. E., Ritz, N. L., Martin, J. A., Wardill, H. R., Cryan, J. F., & Clarke, G. A. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1941711 · Cited by 156
Recent trends in molecular diagnostics of yeast infections: from PCR to NGS
Arastehfar, A. A., Boekhout, T., Butler, G., Cesare, G. B. D., Dolk, E., Gabaldón, T., Hafez, A. I., Hube, B., Hagen, F., Hovhannisyan, H., et al. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz015 · Cited by 144
Hoggard, M., Vesty, A., Wong, G. C., Montgomery, J. M., Fourie, C., Douglas, R. G., Biswas, K., & Taylor, M. W. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02208 · Cited by 132
The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes
Aydin, Ö., Nieuwdorp, M., & Gerdes, V. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1020-6 · Cited by 124
Spisni, E., Petrocelli, G., Imbesi, V., Spigarelli, R., Azzinnari, D., Sarti, M. D., Campieri, M., & Valerii, M. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114152 · Cited by 120
The Mycobiome: A Neglected Component in the Microbiota-Gut-Brain Axis
Enaud, R., Vandenborght, L., Coron, N., Bazin, T., Prével, R., Schaeverbeke, T., Berger, P., Fayon, M. J., Lamireau, T., & Delhaès, L. (2018) · Microorganisms · doi:10.3390/microorganisms6010022 · Cited by 122
The role of gut mycobiome in health and diseases
Zhang, L., Zhan, H., Xu, W., Yan, S., & Ng, S. C. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211047130 · Cited by 118
The Human Mycobiome: Colonization, Composition and the Role in Health and Disease
Belvončíková, P., Šplíchalová, P., Videnska, P., & Gardlík, R. (2022) · Journal of Fungi · doi:10.3390/jof8101046 · Cited by 115
The Mycobiome in Health and Disease: Emerging Concepts, Methodologies and Challenges
Tiew, P. Y., Aogáin, M. M., Ali, N. A. B. M., Thng, K. X., Goh, K., Lau, K. J. X., & Chotirmall, S. H. (2020) · Mycopathologia · doi:10.1007/s11046-019-00413-z · Cited by 113
Gut commensals and their metabolites in health and disease
Krishnamurthy, H. K., Pereira, M., Bosco, J., George, J., Jayaraman, V., Krishna, K., Wang, T., Bei, K., & Rajasekaran, J. J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1244293 · Cited by 112
Skalski, J. H., Limon, J. J., Sharma, P., Gargus, M. D., Nguyen, C., Tang, J., Coelho, A. L., Hogaboam, C. M., Crother, T. R., & Underhill, D. M. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007260 · Cited by 107
Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome
Hasler, W. L., Grabauskas, G., Singh, P., & Owyang, C. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14339 · Cited by 105
Immune activation in irritable bowel syndrome: what is the evidence?
Aguilera‐Lizarraga, J., Hussein, H., & Boeckxstaens, G. E. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00700-9 · Cited by 109
The Gut-Liver Axis in Cholestatic Liver Diseases
Blesl, A., & Stadlbauer, V. (2021) · Nutrients · doi:10.3390/nu13031018 · Cited by 102
Stress-Induced Chronic Visceral Pain of Gastrointestinal Origin
Meerveld, B. G., & Johnson, A. C. (2017) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2017.00086 · Cited by 102
Overview of the Potential Role of Malassezia in Gut Health and Disease
Spatz, M., & Richard, M. L. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00201 · Cited by 99
Gut mycobiomes are altered in people with type 2 Diabetes Mellitus and Diabetic Retinopathy
Jayasudha, R., Das, T., Chakravarthy, S. K., Prashanthi, G. S., Bhargava, A., Tyagi, M., Rani, P. K., Pappuru, R. R., & Shivaji, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243077 · Cited by 98
“ Candida Albicans Interactions With The Host: Crossing The Intestinal Epithelial Barrier”
Basmaciyan, L., Bon, F., Paradis, T., Lapaquette, P., & Dalle, F. (2019) · Tissue Barriers · doi:10.1080/21688370.2019.1612661 · Cited by 89
The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome
Gu, Y., Zhou, G., Qin, X., Huang, S., Wang, B., & Cao, H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01894 · Cited by 87
Roles of the gut virome and mycobiome in faecal microbiota transplantation
Lam, S., Bai, X., Shkoporov, A. N., Park, H., Wu, X., Lan, P., & Zuo, T. (2022) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(21)00303-4 · Cited by 89
Review article: fungal alterations in inflammatory bowel diseases
Lam, S., Zuo, T., Ho, M., Chan, F. K. L., Chan, P. K. S., & Ng, S. C. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15523 · Cited by 87
Host–microbe interactions: commensal fungi in the gut
Paterson, M. J., Oh, S., & Underhill, D. M. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.11.012 · Cited by 82
Microbiota: a novel regulator of pain
Defaye, M., Gervason, S., Altier, C., Berthon, J., Ardid, D., Filaire, E., & Carvalho, F. A. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02083-z · Cited by 81
Alterations of the gut mycobiome in patients with MS
Shah, S., Locca, A., Dorsett, Y., Cantoni, C., Ghezzi, L., Lin, Q., Bokoliya, S. C., Panier, H. A., Suther, C., Gormley, M., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103557 · Cited by 75
Baassiri, M. G. E., Raouf, Z., Badin, S., Escobosa, A., Sodhi, C. P., & Nasr, I. W. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03118-3 · Cited by 81
Haak, B. W., Argelaguet, R., Kinsella, C. M., Kullberg, R. F. J., Lankelma, J. M., Deijs, M., Klein, M., Jebbink, M. F., Hugenholtz, F., Kostidis, S., et al. (2021) · mSystems · doi:10.1128/msystems.01148-20 · Cited by 75
The evolving species concepts used for yeasts: from phenotypes and genomes to speciation networks
Boekhout, T., Aime, M. C., Begerow, D., Gabaldón, T., Heitman, J., Kemler, M., Khayhan, K., Lachance, M., Louis, E. J., Sun, S., et al. (2021) · Fungal Diversity · doi:10.1007/s13225-021-00475-9 · Cited by 79
Gut microbiota profiles and characterization of cultivable fungal isolates in IBS patients
Sciavilla, P., Strati, F., Paola, M. D., Modesto, M., Vitali, F., Cavalieri, D., Prati, G. M., Vito, M. D., Aragona, G., Filippo, C. D., et al. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11264-4 · Cited by 72
Gut mycobiome: A promising target for colorectal cancer
Qin, X., Gu, Y., Liu, T., Wang, C., Zhong, W., Wang, B., & Cao, H. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188489 · Cited by 63
The Role of Short Chain Fatty Acids in Irritable Bowel Syndrome
Jiang, W., Wu, J., Zhu, S., Xin, L., Yu, C., & Shen, Z. (2022) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm22093 · Cited by 70
Altered gut bacterial–fungal interkingdom networks in patients with current depressive episode
Jiang, H., Pan, L., Zhang, X., Zhang, Z., Zhou, Y., & Ruan, B. (2020) · Brain and Behavior · doi:10.1002/brb3.1677 · Cited by 55
The intestinal mycobiota and its relationship with overweight, obesity and nutritional aspects
Gamboa, R. G., Kirchmayr, M. R., Hernandez, M. S. G., Pérez‐Brocal, V., Moyá, A., & González‐Ávila, M. (2021) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12864 · Cited by 55
Mars, R. A. T., Frith, M., & Kashyap, P. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.10.058 · Cited by 53
The fecal mycobiome in patients with Irritable Bowel Syndrome
Das, A., O’Herlihy, E. A., Shanahan, F., O’Toole, P. W., & Jeffery, I. B. (2021) · Scientific Reports · doi:10.1038/s41598-020-79478-6 · Cited by 53
Implicating Dysbiosis of the Gut Fungal Microbiome in Uveitis, an Inflammatory Disease of the Eye
Jayasudha, R., Chakravarthy, S. K., Prashanthi, G. S., Sharma, S., Tyagi, M., & Shivaji, S. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-26426 · Cited by 52
Li, Y., Hong, G., Yang, M. J., Li, G., Jin, Y. T., Xiong, H., Qian, W., & Hou, X. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104936 · Cited by 49
Maternal separation in rodents: a journey from gut to brain and nutritional perspectives
Rincel, M., & Darnaudéry, M. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665119000958 · Cited by 51
The gut–brain axis and pain signalling mechanisms in the gastrointestinal tract
Meerschaert, K. A., & Chiu, I. M. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-01017-9 · Cited by 57
Fecal Fungi Dysbiosis in Nonalcoholic Fatty Liver Disease
You, N., Xu, J., Wang, L., Zhuo, L., Zhou, J., Song, Y., Ali, A., Luo, Y., Yang, J., Yang, W., et al. (2021) · Obesity · doi:10.1002/oby.23073 · Cited by 46
Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies
Camilleri, M., Zhernakova, A., Bozzarelli, I., & D’Amato, M. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00662-2 · Cited by 49
Painful interactions: Microbial compounds and visceral pain
van Thiel, I. A. M., Botschuijver, S., de Jonge, W. J., & Seppen, J. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165534 · Cited by 44
Spore Germination as a Target for Antifungal Therapeutics
Ortiz, S. C., Huang, M., & Hull, C. M. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00994-19 · Cited by 40
The mycobiota of the human body: a spark can start a prairie fire
Zhang, D., Wang, Y., Shen, S., Hou, Y., Chen, Y., & Wang, T. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1731287 · Cited by 41
Hou, Q., Huang, Y., Wang, Y., Liao, L., Zhu, Z., Zhang, W., Liu, Y., Li, P., Chen, X., & Liu, F. (2020) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2002.02059 · Cited by 39
Hong, G., Li, Y., Yang, M. J., Li, G., Qian, W., Xiong, H., Bai, T., Song, J., Zhang, L., & Hou, X. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13891 · Cited by 39
Shin, A., & Kashyap, P. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2195792 · Cited by 34
Botschuijver, S., Welting, O., Levin, E., Ferreira, D. M., Koch, E., Montijn, R. C., Seppen, J., Hakvoort, T. B. M., Schuren, F. H. J., de Jonge, W. J., et al. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13299 · Cited by 38
Candida spp. in Human Intestinal Health and Disease: More than a Gut Feeling
Kreulen, I. A. M., de Jonge, W. J., van den Wijngaard, R. M., & van Thiel, I. A. M. (2023) · Mycopathologia · doi:10.1007/s11046-023-00743-z · Cited by 37
Gut microbiota in gastrointestinal diseases during pregnancy
Liu, Z.-Z., Sun, J., & Wang, W. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i10.2976 · Cited by 36
Bacterial modulation of visceral sensation: mediators and mechanisms
Lomax, A. E., Pradhananga, S., Sessenwein, J. L., & O’Malley, D. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00052.2019 · Cited by 36
Wang, K., Wang, S., Chen, Y., Lu, X., Wang, D., Zhang, Y., Pan, W., Zhou, C., & Zou, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1327503 · Cited by 32
Balmuș, I.-M., Ilie, O., Ciobica, A. S., Cojocariu, R.-O., Stanciu, C., Trifan, A. V., Cîmpeanu, M., CIMPEANU, C. S., & Gorgan, L. (2020) · Medicina · doi:10.3390/medicina56010038 · Cited by 34
Histamine-producing bacteria and their role in gastrointestinal disorders
Fiorani, M., Vecchio, L. E. D., D’Argenio, P., Kaitsas, F., Rozera, T., Porcari, S., Gasbarrini, A., Cammarota, G., & Ianiro, G. (2023) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2023.2230865 · Cited by 32
Steinert, R. E., Rehman, A., Lima, E. S., Agamennone, V., Schuren, F. H. J., Gerö, D., Schreiner, P., Vonlanthen, R., Ismaeil, A., Tzafos, S., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236936 · Cited by 32
The Role of Gut Microbiome in Irritable Bowel Syndrome: Implications for Clinical Therapeutics
Zhao, Y., Zhu, S., Dong, Y., Xie, T., Chai, Z., Gao, X., Dai, Y., & Wang, X. (2024) · Biomolecules · doi:10.3390/biom14121643 · Cited by 32
Gașpar, B. S., Roşu, O. A., Enache, R. M., Profir, M., Pavelescu, L. A., & Creţoiu, S. M. (2025) · Journal of Fungi · doi:10.3390/jof11050333 · Cited by 33
Azzam, S. Z., Cayme, G. J., & Martinez, L. R. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103942 · Cited by 26
Role of Fungal Infections in Carcinogenesis and Cancer Development; A Literature Review
Hosseini, K., Ahangari, H., Chapeland‐Leclerc, F., Ruprich‐Robert, G., Tarhriz, V., & Dilmaghani, A. (2021) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2022.076 · Cited by 29
The Role of Yeasts in Human Health: A Review
Caetano, C. F., Gaspar, C., Martinez‐de‐Oliveira, J., Palmeira‐de‐Oliveira, A., & Rolo, J. (2023) · Life · doi:10.3390/life13040924 · Cited by 31
Fungi, host immune response, and tumorigenesis
Elaskandrany, M., Patel, R., Patel, M. M., Miller, G., Saxena, D., & Saxena, A. D. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00025.2021 · Cited by 28
The role of intestinal mast cell infiltration in irritable bowel syndrome
Cheng, L., Luo, Q., & Chen, S. (2021) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12971 · Cited by 25
Gastrointestinal microbiota alteration induced by Mucor circinelloides in a murine model
Mueller, K. D., Zhang, H., Serrano, C. R., Billmyre, R. B., Huh, E. Y., Wiemann, P., Keller, N. P., Wang, Y., Heitman, J., & Lee, S. C. (2019) · The Journal of Microbiology · doi:10.1007/s12275-019-8682-x · Cited by 25
Microbiota-neuroimmune cross talk in stress-induced visceral hypersensitivity of the bowel
van Thiel, I. A. M., de Jonge, W. J., Chiu, I. M., & van den Wijngaard, R. M. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00196.2019 · Cited by 26
Hurtado‐Lorenzo, A., Honig, G., Weaver, S. A., Larkin, P. B., & Heller, C. A. (2021) · Crohn s & Colitis 360 · doi:10.1093/crocol/otab034 · Cited by 27
Bile acid–gut microbiota crosstalk in irritable bowel syndrome
Gu, Y., Li, L., Yang, M., Liu, T., Song, X., Qin, X., Xu, X. J., Liu, J., Wang, B., & Cao, H. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2058353 · Cited by 26
Ferrocino, I., Ponzo, V., Pellegrini, M., Goitre, I., Papurello, M., Franciosa, I., D’Eusebio, C., Ghigo, E., Cocolin, L., & Bo, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-13438-0 · Cited by 22
Xu, L., Li, W., Lü, L., Zhang, Z., Cui, Z., Jiang, G., Wang, Y., Meng, Q., Wang, Y.-D., Liu, K., et al. (2023) · Current Microbiology · doi:10.1007/s00284-023-03480-0 · Cited by 23
Are there sex differences in visceral sensitivity in young healthy men and women?
Icenhour, A., Labrenz, F., Roderigo, T., Siebert, C., Elsenbruch, S., & Benson, S. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13664 · Cited by 23
Botschuijver, S., van Diest, S. A., van Thiel, I. A. M., Saia, R. S., Strik, A. S., Yu, Z., Ferreira, D. M., Welting, O., Keszthelyi, D., Jennings, G. S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49096-y · Cited by 23
Improved gastrointestinal health for irritable bowel syndrome with metagenome-guided interventions
Meydan, C., Afshinnekoo, E., Rickard, N., Daniels, G., Kunces, L. J., Hardy, T. M., Lili, L., Pesce, S., Jacobson, P., Mason, C. E., et al. (2020) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbaa013 · Cited by 22
Ponzo, V., Ferrocino, I., Goitre, I., Pellegrini, M., Bruno, M., Astegiano, M., Cadario, G., Castellana, E., Bioletto, F., Corvaglia, M. R., et al. (2021) · Nutrients · doi:10.3390/nu13041260 · Cited by 21
Identification of Patulin from Penicillium coprobium as a Toxin for Enteric Neurons
Brand, B., Stoye, N. M., Guilherme, M. D. S., Nguyen, V. T. T., Baumgärtner, J. C., Schüffler, A., Thines, E., & Endres, K. (2019) · Molecules · doi:10.3390/molecules24152776 · Cited by 20
Fungal feelings in the irritable bowel syndrome: the intestinal mycobiome and abdominal pain
van Thiel, I. A. M., de Jonge, W., & van den Wijngaard, R. M. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2168992 · Cited by 20
Losso, J. N. (2021) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-062520-090235 · Cited by 18
Mengzhu, S., Yujie, Z., Song, Y., Guo, J., Tingting, Z., Yuhang, W., Pei, L., & Jianhua, S. (2022) · PubMed Central · doi:10.19852/j.cnki.jtcm.20220719.001 · Cited by 18
Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease
Shi, Y., Li, J., Cai, S., Zhao, H., Zhao, H., Sun, G., & Yang, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1205348 · Cited by 18
Genetic and phenotypic diversity of fecal Candida albicans strains in irritable bowel syndrome
van Thiel, I. A. M., Stavrou, A. A., de Jong, A. W., Theelen, B., Davids, M., Hakvoort, T. B. M., Admiraal, I., Weert, I., Hesselink, M., Vu, D., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09436-x · Cited by 20
Vito, M. D., Bellardi, M. G., Sanguinetti, M., Mondello, F., Girolamo, A., Barbanti, L., Garzoli, S., Sabatino, M., Ragno, R., Vitali, A., et al. (2020) · Nutrients · doi:10.3390/nu12051329 · Cited by 17
Metadata
- Authors
- Botschuijver, S., Roeselers, G., Levin, E., Jonkers, D. M., Welting, O., Heinsbroek, S. E. M., de Weerd, H. H., Boekhout, T., Fornai, M., Masclee, A. A., Schuren, F. H. J., de Jonge, W. J., Seppen, J., & van den Wijngaard, R. M.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Netherlands Organisation for Applied Scientific Research (NL)
- Maastricht University Medical Centre (NL)
- Westerdijk Fungal Biodiversity Institute (NL)
- University of Pisa (IT)
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 153
- Issue
- 4
- Pages
- 1026-1039
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2624678362
- Cited by
- 202
- References
- 50
- Citations by year
- 2026: 12 · 2025: 12 · 2024: 23 · 2023: 19 · 2022: 23 · 2021: 32 · 2020: 31 · 2019: 29 · 2018: 16 · 2017: 5
- FWCI
- 23.23
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, cc-by-nc-nd)
- Research Publications (Maastricht University) (submittedVersion)
- UvA-DARE (University of Amsterdam) (submittedVersion)
- TNO Repository (submittedVersion)
- Repository hosted by TU Delft Library (TU Delft) (submittedVersion)
- Funders
- Danone
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- irritable bowel syndrome, visceral hypersensitivity, fungal dysbiosis, gut fungi, mast cells, Dectin-1, Syk signaling, β-glucan, fungicides, fecal microbiota transplantation, water avoidance stress, maternal separation, nociception, gut-brain axis, rats, human gut microbiome, metabarcoding
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Syk Kinase, Adult, Animals, Antifungal Agents, Anxiety, Separation, Behavior, Animal, Cell Line, Disease Models, Animal, Feces, Female, Fungi, Humans, Hyperalgesia, Intestinal Mucosa, Intestines, Male, Mast Cells, Maternal Deprivation, Middle Aged, Pain Measurement, Cell Degranulation, Abdominal Pain, Case-Control Studies, Pain Threshold, Rats, Long-Evans, Irritable Bowel Syndrome, beta-Glucans, Protein Kinase Inhibitors, Pain Perception, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
